Effects of vitamin D supplements on influenza A illness during the 2009 H1N1 pandemic: a randomized controlled trial
Food Funct., 2014,5, 2365-2370 https://doi.org/10.1039/C4FO00371C
Mitsuyoshi Urashima,*ab Hidetoshi Mezawa,ab Miki Noyaa and Carlos A. Camargo, Jr.c
No indication in the 2014 study as to the vitamin D levels at 2 months
- Respond to daily Vitamin D in 2-12 months chart shows only only half probably got above 30 ng
Guess of % > 30 ng in this study - Half the risk of Influenza -A in infants taking 1200 IU of vitamin D for 4 months – RCT Jan 2018
- Overview Influenza and vitamin D
- Vitamin D probably can both prevent Influenza and augment vaccine prevention – Aug 2018
- Influenza prevented by 40 ng levels or treated with vitamin D hammer (50,000 IU) – June 2015
- 7X less risk of influenza if Vitamin D levels higher than 30 ng – Oct 2017
- This Vitamin Shown to Be Almost 10 Times More Effective Than the Flu Shot – Feb 2017 Mercola
- FLU FAQ
- Reduce probability of getting the Flu
- Colds and flu prevented and treated by Vitamin D - many studies
Flu has the following
Vitamin D fights all phases of Influenza
- FACT: Vitamin D PREVENTS Influenza 7X lower risk
- FACT: Vitamin D TREATS Influenza ( Vitamin D Hammer )
- Single dose of 50,000 IU of vitamin D stops Influenza symptoms
- FACT: Vitamin D PREVENTS & TREATS Sepsis which is a rare but deadly consequence of Influenza
- FACT: Vitamin D enhances the activity of vaccines.
- FACT: Vitamin D has virtually no side effects
- but 1 in 300 get people get muscle pain or itching due to lower magnesium levels
- FACT: Vitamin D prevents/treats over 120 health problems (left column)
- FACT: Do not take vitamin D if Sarcoidosis, excess Calcium, Chemotherapy
- CONCLUSION To help protect/treat influenza, take 50,000 IU of Vitamin D once a week
during the flu season if you are an average weight adult
Download the PDF from sci-hub via Vitamin D Life
In a prior randomized trial, we found that the incidence of influenza A was less in the vitamin D3 group than among those on placebo, but the total incidence of either influenza A or B did not differ between groups. In this trial, the incidence of influenza A or B was less in the vitamin D3 group than in the placebo group only during the first half of the study. To elucidate whether vitamin D3 has preventive actions against influenza A, we conducted another trial during the 2009 pandemic of the H1N1 subtype of influenza A. Students (n = 247) of a Japanese high school were randomly assigned to receive vitamin D3 supplements (n = 148; 2000 IU per day) or a placebo (n = 99) in a double-blind study for 2 months. The primary outcome was incidence of influenza A diagnosed by a rapid influenza diagnostic test by medical doctors. Influenza A was equally likely in the vitamin D3 group (20/148: 13.5%) compared with the placebo group (12/99: 12.1%). By post hoc analysis, influenza A occurred significantly less in the vitamin D3 group (2/148: 1.4%) compared with the placebo group (8/99: 8.1%) (risk ratio, 0.17; 95% confidence interval, 0.04 to 0.77; P = 0.009) in the first month. However, during the second month, the vitamin D3 group experienced more events and effectively caught up with the placebo group. Vitamin D3 supplementation did not lower the overall incidence of influenza A during the 2009 H1N1 pandemic. A post hoc analysis suggests that the initial benefit during the first month of treatment was lost during the second month.